DTX-P7, a Peptide–Drug Conjugate, Is Highly Effective for Non-Small Cell Lung Cancer

Investigators constructed a cooperatively combating conjugate (DTX-P7) composed of docetaxel (DTX) and a heptapeptide, which specifically bound to cell surface Hsp90, and assessed the anti-tumor effects of DTX-P7 on non-small cell lung cancer.